Annotation Detail for CACNB1
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04010 | MAPK signaling pathway |
hsa05410 | Hypertrophic cardiomyopathy (HCM) |
hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
hsa05414 | Dilated cardiomyopathy |
hsa04260 | Cardiac muscle contraction |
Pathway ID | Pathway Name |
---|
| Synaptic Transmission |
| Axon guidance |
Pathway ID | Pathway Name |
---|
P00003 | Alzheimer disease-amyloid secretase pathway |
P04378 | Beta2 adrenergic receptor signaling pathway |
P00039 | Metabotropic glutamate receptor group III pathway |
P04391 | Oxytocin receptor mediated signaling pathway |
P04377 | Beta1 adrenergic receptor signaling pathway |
P00044 | Nicotinic acetylcholine receptor signaling pathway |
P04394 | Thyrotropin-releasing hormone receptor signaling pathway |
P04374 | 5HT2 type receptor mediated signaling pathway |
P00040 | Metabotropic glutamate receptor group II pathway |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CACNB1 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CACNB1 mRNA | affects expression | 16483693
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of CACNB1 mRNA | decreases expression | 20360939
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of CACNB1 mRNA | increases expression | 18175754
|
C025643 |
vinclozolin |
vinclozolin affects the expression of CACNB1 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
3.03 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.44 | 18056438 19061943 19052882 17620307 17162532 16434500 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.45 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.93 | 19015723 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.19 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.98 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
2.98 | 19171122 3581430 17761372 17428255 17138121 16878318 19208518 18785209 16502159 18691550 16328049 19394651 20514400 19919837 18393292 16698587 18506893 19107877 20727157 19418558 16569478 16807293 17978847 18665156 16288022 16681979 17173139 17162532 16935385 20432363 20214788 20512989 18210153 10672840 19822196 10737359 3084413 17055752 11831363 20935162 19701751 19519916 19052882 18978308 21159647 16830150 16779866 18056438 20007298 20084675 20524982 18494052 19539802 18788625 16540662 19383236 19335982 18971187 20101231 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.77 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.09 | 2727394 7505956 21159647 17174075 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
4.01 | 19052882 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.24 | 15894690 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.78 | 14966744 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.10 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.25 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.73 | 19739265 12392966 19416960 11529661 11287661 16393943 14725611 11743745 11739529 10663392 16109766 19370779 16781746 17562736 11461765 15619225 12705907 16485898 18713872 10774834 10915739 14550746 18071297 19420014 16081117 12153990 17906064 12540782 19923254 16227642 12958197 15968718 11421492 16177239 12594235 2444490 11834606 17522070 19164858 14986274 19085960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.73 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.73 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.71 | 19426721 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.73 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.56 | 20387270 21071580 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.29 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.47 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.91 | 16417039 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.99 | 16870215 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.26 | 16467254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.53 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.49 | 14714311 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.38 | 12587719 15629191 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.27 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.99 | 20032147 19638242 18522880 18407596 18665156 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.15 | 12587719 12969438 19784758 16611625 19014921 11587558 19460945 16610002 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
4.15 | 17034775 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.58 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.34 | 21071580 19638242 20118626 15175105 19833225 12771043 2862719 19499222 10737359 19254457 19642983 20137499 2422723 20101389 19996281 18648771 20405173 21278145 19256749 20452335 20492335 18977376 18978307 19812893 15885732 19294768 19090486 12112319 20501860 19690152 20434301 16942905 20583210 19073162 21167192 18754104 19850985 18644402 9163691 19427195 21047994 19426721 19255062 19551842 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.83 | 19126423 17942915 18164116 2563599 18253720 19519916 18093689 18308698 18079962 19009564 18775883 19539802 18544905 17174075 21159647 16267830 9362446 3124819 16842330 19004024 17854601 18282651 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 21163286 20970405 20512841 6695378 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.46 | 14737004 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.05 | 19513568 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.68 | 3581430 9029167 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
9.22 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
9.22 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.73 | 20387270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.69 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.52 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.88 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.44 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.47 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.47 | 18629315 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.25 | 7505956 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.38 | 10982225 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00308 |
activator |
Ibutilide |
Anti-Arrhythmia Agents |
DB00393 |
blocker |
Nimodipine |
Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |
DB00653 |
- |
Tetra Fungistop |
Anticonvulsants;Analgesics;Calcium Channel Blockers;Anesthetics;Anti-Arrhythmia Agents;Tocolytic Agents |
DB00661 |
blocker |
Tarka |
Vasodilator Agents;Antiarrhythmic Agents;Calcium Channel Blockers;Anti-Arrhythmia Agents |
DB01388 |
antagonist |
Mibefradil |
Antihypertensive Agents;Vasodilator Agents;Calcium Channel Blockers |